Frankfurt am Main, Germany

Axel Leimer



 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Axel Leimer in Tissue Adhesives

Introduction: Axel Leimer, based in Frankfurt am Main, Germany, is a prominent inventor credited with seven patents. His work primarily revolves around the development of advanced tissue adhesives utilizing self-assembling polypeptides, which have significant implications in the medical field.

Latest Patents: Among Axel Leimer's notable innovations are several patents focusing on the use of self-assembling polypeptides. One patent describes a method for using a silk polypeptide, including a spider silk polypeptide, as a tissue adhesive. This invention proposes applications for gluing cosmetic and pharmaceutical compounds to skin, mucosa, and hair, demonstrating versatility beyond traditional medical applications. Additionally, another patent addresses the use of self-assembling polypeptides as coating materials for implants to reduce or prevent capsular fibrosis, thereby enhancing the safety and effectiveness of medical implants in the human body.

Career Highlights: Axel Leimer is currently affiliated with Amsilk GmbH, a company dedicated to developing biotechnological solutions through silk proteins. His expertise and innovative approach have positioned him as a valuable asset in the field, contributing to advancements in medical adhesives and regenerative medicine.

Collaborations: Throughout his career, Axel has collaborated with talented colleagues, including Lin Romer and Lin Römer, who share his vision for pioneering novel applications of biomaterials. These partnerships have fostered a creative environment that leads to groundbreaking innovations.

Conclusion: Axel Leimer's contributions to the field of tissue adhesives through his inventive use of self-assembling polypeptides are noteworthy. With a strong foundation in research and development at Amsilk GmbH, his work continues to push the boundaries of medical technology and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…